Why CLINUVEL and these ASX shares have doubled in value in 12 months

The CLINUVEL Pharmaceuticals Limited (ASX:CUV) share price is one of three that have doubled over the last 12 months…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the last 12 months the All Ordinaries Index has carved out a gain of 6.3% excluding dividends.

Whilst this is a positive gain, it pales in comparison to some of the gains that have been made on the index.

Three shares that have doubled in value over the period are listed below. Here's why they have rocketed higher:

The CLINUVEL Pharmaceuticals Limited (ASX: CUV) share price has rocketed 155% higher since this time last year. The main catalyst for this has been the impressive sales growth of the company's SCENESSE product and upcoming regulatory reviews. SCENESSE has been developed as a first-line pharmaceutical product aimed at treating patients with the rare genetic disorder erythropoietic protoporphyria (EPP). Sales have been growing strongly in FY 2019 and could be given a major boost in the coming months if the US Food and Drug Administration gives it the tick of approval at its Priority Review meeting in July. I like CLINUVEL but I feel its shares are looking expensive at current levels.

The IDP Education Ltd (ASX: IEL) share price has jumped 103% over the last 12 months. The main driver of this gain was the student placement services and language testing company's first half result which smashed expectations. IDP Education posted a 26% increase in total half year revenue to $304.3 million and a 34% jump in net profit after tax to $40.7 million. The Student Placement segment was a strong performer once again, growing revenue by 36% to $90.7 million thanks to a 23% lift in volumes and a 14% increase in the average application processing fee. Although I think its shares are fully valued now, I feel IDP Education could still be a great long-term investment.

The Pro Medicus Limited (ASX: PME) share price has risen a massive 121% since this time last year. The healthcare technology company's shares have been on a very positive run since the release of its half year result in February. During the first half of FY 2019 Pro Medicus posted a 59.4% increase in half year revenue to $25.3 million and a 79.9% jump in underlying net profit after tax to $9.2 million. Strong demand for its popular Visage health imaging software in all its key markets drove the impressive result. As with IDP Education, I feel that its shares look fully valued now, but could still be a great long-term investment.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Block, DroneShield, EBR Systems, and Insignia shares are racing higher

These shares are starting the week on a high. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which All Ords ASX healthcare stock just surged 11% on FDA news

Investors are sending the ASX healthcare stock soaring on Monday.

Read more »

a man sits on a rocket propelled office chair and flies high above a city
Technology Shares

DroneShield share price rockets 9% on 'significant' new contract

ASX investors are sending the DroneShield share price flying higher on Monday.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

These shares are ending the week with a bang. But why? Let's find out.

Read more »

A woman wearing headphones looks delighted and animated on news she's receiving from her mobile phone that she is holding close to her face.
Share Gainers

Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today

These shares are starting the year in a positive fashion. But why?

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

These were the 5 best performing ASX 200 shares in 2024

Let's see why these shares delivered massive returns last year.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

These were the best ASX 200 shares to own in December

Let's see why these shares outperformed the market in December.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why DroneShield, Invictus Energy, Mesoblast, Weebit Nano shares are rising today

These shares are on course to end the year on a positive note. But why?

Read more »